Drug prices
Finally! Humira’s biosimilars also hit the us market!
Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :
Andre Wencker
September 21, 2023
CMS issued guidance on August 19th, removing barriers to COVID-19 diagnostic testing and vaccinations and strengthening requirements that plans and issuers cover diagnostic testing and vaccines administration without cost sharing, prior authorization, or other medical management requirements imposed by the plan or issuer. For example, covered individuals wanting to ensure they are COVID-19 negative prior to visiting a family member would be able to be tested without paying a copay.
The vaccine itself will be paid for through funding authorized by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, but administration of the vaccine by a provider will be paid for by the plan sponsor (employer or insurer).
Issuers of non-grandfathered group or individual health insurance coverage are required to cover without cost sharing the vaccine and its administration when provided by a network provider, and during the COVID-19 PHE (Public Health Emergency), are also required to cover without cost sharing the vaccine and its administration when provided by an out-of-network provider. Providers are prohibited by agreement with the U.S. Government from billing patients for the vaccine or its administration, including balance billing.
You probably read about the $200 penalty an airline company imposed to non-vaccinated employees. You should know that many employers are considering it, especially since the FDA’s Pfizer vaccine approval. Following a recent survey by Mercer, a solid majority of 66% of the surveyed employees said they would want their own employer to implement a vaccine mandate; only 21% opposed.
“In fact, even before the TiC rules, prices were available by simply asking them, thanks to an ACA requirement”, said Leon Wisniewski, founder and CEO at Healthcostlabs. (https://www.healthcostlabs.com/).
Leon worked a long time for insurers as an actuary. Leon is a strong advocate for affordable and quality healthcare and shares his insights about Data Usage Agreements (DUA’s).
He has built a service providing clients with lower cost alternatives using millions of rates grouped by MSA Regions, insurers and health plans, hospitals, and services. The data comes straight from hospital files. As of today, he has roughly 60% of all hospitals in his database and is constantly updating it.
He does also plan on adding the carriers’ fee schedule files when they become available in January 2022.
Among the different tables Leon shared with us, we chose 3 key examples:
The percentage of employees who want their employers to implement a vaccine mandate seems roughly equivalent to the percentage of Americans of working age who are vaccinated, the author noticed.
This has some employers turning to alternative strategies to encourage vaccination, such as a premium surcharge on health insurance (like Delta Airlines did, with a hefty 200$ monthly surcharge…).
Other alternatives to vaccination include stricter masking protocols and regular testing for the virus, as well as restrictions on travel and client meetings. If feasible, employers can give the non-vaccinated the opportunity to continue to work remotely (they just need to be careful that they don’t give only the non-vaccinated work flexibility).
One way or another, employers will need to demonstrate that they have a safe workplace.
We would be interested to know what employers in our network are considering doing on these issues in the coming months.
We can send anyone who is interested the 18-page resource from the CDC providing extensive information on what health plans have to cover with regard to COVID-19 expenses. You can also access it here.
Humira was first marketed in 2002 and was protected in the US market until 2023, thanks to AbbVie’s use of two strategies :
After wrapping up the 2023 enrollment, employers are now planning their next moves to mitigate the continuously growing healthcare costs impacting their plans. This is particularly true for pharmacy costs.
PhRMA, a Big Pharma lobbying group, released an advertising touting that drug prices were not fueling inflation. To prove it, they produce the graphic below.
Care2Care secured a strategic partnership with an innovative, transparent, 100% pass-through PBM.
Adding to our expertise in international drug sourcing, we expand our offer to the full pharmacy benefit management.
